Notify me when Austin W. Greenhouse David M. Marxe files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2014 | 148 | $733,192,000 | +$90,591,647 | -$139,528,056 | -$48,936,409 | Ziopharm Oncology Inc (R/R) @4, PFSW, KOPN, VCRA, UCTT | 13F-HR | 14 Nov 2014, 11:32 |
| Q2 2014 | 140 | $789,310,000 | +$99,988,081 | -$97,211,851 | +$2,776,230 | Ziopharm Oncology Inc (R/R) @4, KOPN, OVTI, CEVA, PFSW | 13F-HR | 08 Aug 2014, 15:13 |
| Q1 2014 | 135 | $903,003,000 | +$64,663,047 | -$165,602,930 | -$100,939,883 | Ziopharm Oncology Inc (R/R) @4, UCTT, PRKR, ADEP, BWEN | 13F-HR | 14 May 2014, 15:32 |
| Q4 2013 | 134 | $933,072,000 | $0 | $0 | $0 | Ziopharm Oncology Inc (R/R) @4, ARWR, ADEP, PRKR, UCTT | 13F-HR | 06 Feb 2014, 16:05 |